You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 174 No. 3, September 17, 1960 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypotensive Agents and Pressor Substances

The Effect of Epinephrine, Norepinephrine, Angiotensin II, and Others on the Secretory Rate of Aldosterone in Man

John H. Laragh, M.D.; Marielena Angers, M.D.; William G. Kelly, Ph.D.; Seymour Lieberman, Ph.D.

JAMA. 1960;174(3):234-240.


Abstract

The effect of hypotensive agents and of pressor substances on the rate of secretion of aldosterone was determined in normal subjects and in patients with hypertension or edema. The medullary hormones were studied because, in excess, they can produce hypertension in man. Angiotensin was studied because the major pathology of malignant hypertension is renal. The present work indicates that induced changes in the arterial blood pressure do not necessarily affect aldosterone secretion. The medullary hormones modified aldosterone output in a variable way, depending in part on the state of sodium balance. In contrast to the catecholamines, angiotensin consistently produced an increased secretion of aldosterone. The results suggest that aldosterone may regulate salt balance and blood pressure by its interaction with pressor substances such as angiotensin.



Author Affiliations

New York

From the Departments of Medicine, Obstetrics and Gynecology, and Biochemistry, College of Physicians and Surgeons, Columbia University, and The Presbyterian Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Regulation of Type 1 Angiotensin II Receptor in Adrenal Gland : Role of {alpha}1-Adrenoreceptor
Wang et al.
Hypertension 1997;30:345-350.
ABSTRACT | FULL TEXT  

Association of Hypotension With Hyperreninemic Hypoaldosteronism in the Critically Ill Patient
Davenport and Zipser
Arch Intern Med 1983;143:735-737.
ABSTRACT  

The Kidney and Hypertension
Ferris
Arch Intern Med 1982;142:1889-1895.
ABSTRACT  

Renin Profiling for Diagnosis and Treatment of Hypertension
Laragh et al.
JAMA 1979;241:151-156.
ABSTRACT  

Disparate Patterns of Aldosterone Response During Diuretic Treatment of Hypertension
WEBER et al.
ANN INTERN MED 1977;87:558-563.
ABSTRACT  

Clinical Implications of Renin in the Hypertensive Patient
Brunner and Gavras
JAMA 1975;233:1091-1093.
ABSTRACT  

The Physiology of Renin
Stein and Ferris
Arch Intern Med 1973;131:860-872.
ABSTRACT  

The Role of Aldosterone in Renal Physiology
Knochel and White
Arch Intern Med 1973;131:876-884.
ABSTRACT  

Salt Loading in Renal Aldosteronism Before and After Nephrectomy
Rado et al.
Arch Surg 1969;98:357-364.
ABSTRACT  

Aldosterone Production After Suppression of Corticotropic Secretory Activity
Spark et al.
Arch Intern Med 1968;122:394-398.
ABSTRACT  

Renin in the Diagnosis of Renovascular Hypertension: Activity in Renal and Peripheral Vein Plasma
Winer et al.
JAMA 1967;202:121-128.
ABSTRACT  

Malignant Hypertension Following Thrombosis of a Renal Artery
MILLER and FOSTER
Arch Surg 1966;93:962-966.
ABSTRACT  

Electrolyte Excretion by Sweat Glands and Kidneys: During Suppression of Adrenal Corticosteroid Activity By Methopyrapone and Spironolactone
MAY
Arch Pediatr Adolesc Med 1965;109:2-8.
ABSTRACT  

Aldosterone and Angiotensin
Davis
JAMA 1964;188:1062-1068.
ABSTRACT  

Normal Arterial Pressure in Patients With Renal Arterial Stenosis
Dustan et al.
JAMA 1964;187:1028-1029.
ABSTRACT  

Aldosterone Antagonists in Diuretic Therapy: Their Effect on the Refractory Phase
SELLER et al.
Arch Intern Med 1964;113:350-355.
ABSTRACT  

Diagnosis of Renal Arterial Lesions
WILSON et al.
Arch Intern Med 1963;112:270-277.
ABSTRACT  

The Granularity of the Juxtaglomerular Cells in Human Hypertension: Histologic and Clinical Correlations
ITSKOVITZ et al.
ANN INTERN MED 1963;59:8-23.
ABSTRACT  

Hyperaldosteronism and Hypergranularity of the Juxtaglomerular Cells in Renal Hypertension: Metabolic Studies
GOLDBERG and MCCURDY
ANN INTERN MED 1963;59:24-36.
ABSTRACT  

Effect of Alpha-Methyl DOPA in Severe and Malignant Hypertension
Cannon et al.
JAMA 1962;179:673-681.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.